title: Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
authors.forename: J N
authors.initials: JN
authors.lastname: Berman
authors.forename: R B
authors.initials: RB
authors.lastname: Gerbing
authors.forename: T A
authors.initials: TA
authors.lastname: Alonzo
authors.forename: P A
authors.initials: PA
authors.lastname: Ho
authors.forename: K
authors.initials: K
authors.lastname: Miller
authors.forename: C
authors.initials: C
authors.lastname: Hurwitz
authors.forename: N A
authors.initials: NA
authors.lastname: Heerema
authors.forename: B
authors.initials: B
authors.lastname: Hirsch
authors.forename: S C
authors.initials: SC
authors.lastname: Raimondi
authors.forename: B
authors.initials: B
authors.lastname: Lange
authors.forename: J L
authors.initials: JL
authors.lastname: Franklin
authors.forename: A
authors.initials: A
authors.lastname: Gamis
authors.forename: S
authors.initials: S
authors.lastname: Meshinchi
mesh_terms: D002648:Child; D005787:Gene Frequency; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics* / Q000401:mortality; D009154:Mutation; D015995:Prevalence; D018570:Risk Assessment